CLVSQ — CLOVIS ONCOLOGY INC
CLVSQ (CLOVIS ONCOLOGY INC) is tracked on HoldingsHub across five years of quarterly 13F filings. 30 funds have reported positions historically, with the sum of their latest reported stakes valued at $22.14M. No fund in our coverage reported a position in the latest filing period, which typically means the stock has fallen out of the tracked funds' portfolios rather than that it cannot be bought.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
| Fund | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
| Vanguard Group history | Q3 2022 | 10.21M | $12.15M | 0.00% | Reduce |
| Renaissance Technologies history | Q3 2022 | 2.21M | $2.63M | 0.00% | Reduce |
| Geode Capital Management history | Q3 2022 | 1.38M | $1.65M | 0.00% | Hold |
| Millennium Management history | Q3 2022 | 976.38K | $1.16M | 0.00% | Reduce |
| Citadel Advisors history | Q3 2022 | 599.48K | $714.00K | 0.00% | Reduce |
| Wellington Management Group history | Q3 2022 | 560.57K | $667.00K | 0.00% | Add |
| Morgan Stanley history | Q3 2022 | 483.59K | $576.00K | 0.00% | Reduce |
| Marshall Wace history | Q3 2022 | 310.12K | $370.00K | 0.00% | Add |
| MFS Investment Management history | Q4 2021 | 125.55K | $340.00K | 0.00% | Reduce |
| Northern Trust Corp history | Q3 2022 | 273.23K | $326.00K | 0.00% | Add |
| Bank of America Corp history | Q3 2022 | 210.96K | $251.00K | 0.00% | Add |
| Goldman Sachs Group history | Q3 2022 | 139.90K | $166.00K | 0.00% | Reduce |
| Two Sigma Investments history | Q2 2022 | 74.71K | $134.00K | 0.00% | Reduce |
| Deutsche Bank AG history | Q1 2022 | 64.48K | $131.00K | 0.00% | Reduce |
| Principal Global Investors history | Q3 2022 | 103.64K | $123.00K | 0.00% | Reduce |
| BNY Mellon history | Q3 2022 | 98.00K | $117.00K | 0.00% | Add |
| Manulife Financial history | Q1 2022 | 53.00K | $107.00K | 0.00% | Reduce |
| T. Rowe Price Associates history | Q3 2022 | 85.90K | $103.00K | 0.00% | Reduce |
| Invesco Ltd history | Q1 2022 | 49.95K | $101.00K | 0.00% | Add |
| Wells Fargo & Co history | Q3 2022 | 80.28K | $96.00K | 0.00% | Add |
New Positions (latest)
No fund opened a new position this quarter.
Fully Exited (vs previous quarter)
No tracked fund fully exited this quarter.
Fund Position History — shares by quarter (top 20 funds)
| Fund | Q1 2021 | Q2 2021 | Q3 2021 | Q4 2021 | Q1 2022 | Q2 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|
| Vanguard Group | 7.62M | 9.91M | 12.29M | 10.12M | 12.35M | 11.22M | 10.21M |
| Renaissance Technologies | — | — | 116.70K | 610.40K | 1.46M | 2.29M | 2.21M |
| Geode Capital Management | — | — | 2.02M | 2.21M | 2.10M | 1.38M | 1.38M |
| Millennium Management | — | — | 584.17K | 1.08M | 3.60M | 5.40M | 976.38K |
| Citadel Advisors | — | — | 782.30K | 583.74K | 1.27M | 1.52M | 599.48K |
| Wellington Management Group | — | — | — | 433.98K | 466.65K | 466.65K | 560.57K |
| Morgan Stanley | — | — | 1.04M | 364.54K | 628.76K | 701.70K | 483.59K |
| Marshall Wace | — | — | — | — | — | 86.24K | 310.12K |
| Northern Trust Corp | — | — | 1.13M | 1.17M | 1.11M | 248.41K | 273.23K |
| Bank of America Corp | — | — | 75.09K | 1.72M | 254.32K | 209.89K | 210.96K |
| Goldman Sachs Group | — | — | 503.75K | 494.46K | 297.02K | 241.62K | 139.90K |
| Principal Global Investors | — | — | 686.70K | 439.43K | 303.69K | 255.38K | 103.64K |
| BNY Mellon | — | — | 377.30K | 368.66K | 371.30K | 70.52K | 98.00K |
| T. Rowe Price Associates | — | — | 100.04K | 159.84K | 172.94K | 123.45K | 85.90K |
| Wells Fargo & Co | — | — | 188.04K | 158.51K | 105.89K | 47.74K | 80.28K |
| Charles Schwab Investment Management | — | — | 746.07K | 851.62K | 928.24K | 573.48K | 58.00K |
| D. E. Shaw & Co | — | — | 13.76K | 364.39K | 428.51K | — | 44.92K |
| JPMorgan Chase & Co | — | — | 51.45K | 56.36K | 69.77K | 5.64K | 10.18K |
| Fidelity Management & Research (FMR) | — | — | 1 | — | 137.04K | 4.95K | 3.74K |
| UBS Group AG | — | — | 947.50K | 1.10M | 4.37K | 4.30K | 4.24K |